Barrington Research analyst Kevin Steinke downgrades Echo Global Logistics (NASDAQ:ECHO) from Outperform to Market Perform.
Reported Late Wednesday Feb 22, Aprea Therapeutics Announces Pricing Of $5.5M Underwritten Public Offering Of 1.05M Shares Of Common Stock At A Price Of $5.25/Share
Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea", or the "Company"), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targeting DNA damage response
